0.670
0.02 (2.29%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (MY) | Mixed | - |
| Drug Manufacturers - Specialty & Generic (Global) | Bullish | Bullish | |
| Stock | RHONEMA | Mixed | Mixed |
|
Rhone Ma Holdings Bhd is an investment holding company and are engaged in the provision of management services. It operates through its subsidiaries so it offers animal health services as well as the manufacturing and distribution of animal health products. The operating segments of the group are Animal health products and equipment , Food ingredients, and Others. Animal health products and equipment segment includes marketing, trading, distribution and manufacturing of animal health products and undertaking research and development activities related to animal health, food safety and agriculture in animal health products. The animal health products offered include vaccines, pharmaceuticals, and feed additives. It is also involved in the distribution and supply of food ingredients. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Value |
No data within this time range.
| Name | Avg. Buy ($) | Avg. Sell ($) | Net Quantity | Net Value ($) |
|---|---|---|---|---|
| DR LIM BAN KEONG | 0.665 | - | 42,000 | 27,930 |
| Aggregate Net Quantity | 42,000 | |||
| Aggregate Net Value ($) | 27,930 | |||
| Aggregate Avg. Buy ($) | 0.665 | |||
| Aggregate Avg. Sell ($) | - | |||
| Name | Holder | Date | Type | Quantity | Price | Value ($) |
|---|---|---|---|---|---|---|
| DR LIM BAN KEONG | Director | 17 May 2024 | Acquired (+) | 21,000 | 0.665 | 13,965 |
| DR LIM BAN KEONG | Substantial Shareholder | 17 May 2024 | Acquired (+) | 21,000 | 0.665 | 13,965 |
| Date | Type | Details |
|---|---|---|
| 25 Apr 2024 | Announcement | Annual Report & CG Report - 2023 |
| 24 Apr 2024 | Announcement | General Meetings: Notice of Meeting |
| 17 Apr 2024 | Announcement | RHONEMA - Notice of Book Closure |
| 16 Apr 2024 | Announcement | Final Dividend |
| 13 Mar 2024 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - MR FOONG KAM WENG |
| 13 Mar 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - MR FOONG KAM WENG |
| 13 Mar 2024 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| 29 Feb 2024 | Announcement | Changes in Director's Interest (Section 219 of CA 2016) - DR LIM BAN KEONG |
| 29 Feb 2024 | Announcement | Changes in Sub. S-hldr's Int (Section 138 of CA 2016) - DR LIM BAN KEONG |
| 29 Feb 2024 | Announcement | DEALINGS IN LISTED SECURITIES (CHAPTER 14 OF LISTING REQUIREMENTS) : Dealings Outside Closed Period |
| TTM Dividend Yield | 2.99% |
| 5Y Average Dividend Yield | 2.28% |
| Ex Date | Announcement Date | Payment Date | Details |
|---|---|---|---|
| 27 Jun 2024 | 16 Apr 2024 | 15 Jul 2024 | 0.01 Cash |
| 05 Jan 2024 | 15 Dec 2023 | 02 Feb 2024 | 0.01 Cash |
| 28 Jun 2023 | 11 Apr 2023 | 17 Jul 2023 | 0.01 Cash |
| 30 Dec 2022 | 15 Dec 2022 | 16 Jan 2023 | 0.01 Cash |
| 01 Jul 2022 | 12 Apr 2022 | 15 Jul 2022 | 0.01 Cash |
| 12 Jan 2022 | 24 Dec 2021 | 25 Jan 2022 | 0.01 Cash |
| 01 Jul 2021 | 04 Jun 2021 | 15 Jul 2021 | 0.01 Cash |
| 02 Jul 2020 | 06 May 2020 | 15 Jul 2020 | 0.01 Cash |
| 02 Jul 2019 | 29 Apr 2019 | 15 Jul 2019 | 0.02 Cash |
| 29 Jan 2019 | 15 Jan 2019 | 13 Feb 2019 | 0.01 Cash |
Annual Dividend Yield
| Year | Annual Dividend ($) | Frequency/Year | Yield % |
|---|---|---|---|
| 2024 | 0.020 | 2 | 2.99 |
| 2023 | 0.020 | 2 | 2.90 |
| 2022 | 0.020 | 2 | 2.94 |
| 2021 | 0.010 | 1 | 1.35 |
| 2020 | 0.010 | 1 | 1.24 |
| 2019 | 0.030 | 2 | 4.51 |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |